TECX
NASDAQ · Biotechnology
Tectonic Therapeutic Inc
$27.00
-0.21 (-0.77%)
Open$27.30
Previous Close$27.21
Day High$27.59
Day Low$26.38
52W High$39.53
52W Low$14.39
Volume—
Avg Volume169.8K
Market Cap531.94M
P/E Ratio—
EPS$-4.46
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+37.9% upside
Current
$27.00
$27.00
Target
$37.23
$37.23
$31.47
$37.23 avg
$57.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 64.42M | 64.45M | 57.14M |
| Net Income | 9.98M | 8.55M | 7.27M |
| Profit Margin | 15.5% | 13.3% | 12.7% |
| EBITDA | 14.26M | 12.01M | 10.46M |
| Free Cash Flow | 6.92M | 8.94M | 6.74M |
| Rev Growth | +22.9% | -2.6% | -4.3% |
| Debt/Equity | 0.17 | 0.17 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |